~~<i id='9FE4FAB70D'><strike id='9FE4FAB70D'><tt id='9FE4FAB70D'><pre id='9FE4FAB70D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

hotspot

author：hotspot 2025-09-03 09:23:42 - browse：6272

Photo illustration of a single pill on a large white field – opinion coverage from STAT — Adobe

This time last year, members of Congress were working around the clock to draft and pass the Inflation Reduction Act.

One of their goals was to address government spending on health care. But they specifically didn’t want to discourage research into rare disease treatments, so they exempted some of these so-called orphan drugs from the law.

Unfortunately, the exemptions aren’t working as intended. Unless Congress acts, the IRA threatens to unravel one of America’s greatest medical and public policy success stories: the explosion of new treatments for patients living with rare diseases.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Did you have Obamacare on your GOP debate bingo card?

knowledge

focus

knowledge

leisure time

entertainment

knowledge

ExactSciences'headquartersinMadison,Wis.WikimediaCommonsExactSciencesreportedfirst-quarterrevenuesth

WSS

More tobacco lobbyists active in statehouses

Orangutan used medicinal plant to treat wound, first time ever seen

Biogen shutters digital health group, ends Apple study, in cost cutting move

FDA advisers vote against ALS treatment from BrainStorm

Element Biosciences CEO lays out genome sequencing strategy

Kaiser Permanente unions announce official strike date

leisure time

hotspot

knowledge

Medicare details structure of new drug price negotiation program

After a drawn out lobbying fight, ARPA

Wildfire smoke exposes gaps in outdoor worker protections

Biogen shutters digital health group, ends Apple study, in cost cutting move

Heart attack and stroke risk calculators need revising

Element Biosciences CEO lays out genome sequencing strategy

DIEP, the 'gold standard' of breast reconstruction, is under threat

H5N1 bird flu found in pasteurized milk: what we know

Novavax promises a turnaround & Lilly roils the obesity market

After traumatic brain injury, life support decisions can use more time

focus

Medicare drug price negotiation program allowed for now

Mindstrong's demise and the future of mental health care

Covid vaccines: Private market messier than government rollout

Did you have Obamacare on your GOP debate bingo card?

Cancer researcher Catriona Jamieson is sending tumors into space

Ionis has late

knowledge

leisure time

entertainment

knowledge